Funding for this research was provided by:
Patient-Centered Outcomes Research Institute (CDRN #1306-04912)
Text and Data Mining valid from 2019-04-05
Received: 12 July 2018
Accepted: 21 March 2019
First Online: 5 April 2019
Ethics approval and consent to participate
: The PaTH CDRN utilizes a central Institutional Review Board approach which governs the ethics of the entire process. The Johns Hopkins University School of Medicine (FederalWide Assurance 00005752) institutional review board approved this study (JHU IRB00064600). All participants provided electronic or written informed consent to participate, electronic consent was approved by the Johns Hopkins University School of Medicine institutional review board.
: Not applicable, all information is reported in the aggregate.
: Dr. Nazarian is a scientific advisor to Biosense Webster, Siemens, Imricor, and CardioSolv Inc. and principal investigator for research funding to the University of Pennsylvania from Biosense Webster, Siemens, and Imricor Inc. Dr. Jain receives research support from Medtronic and is a principal investigator for research funding to the University of Pittsburgh from Medtronic, Boston Scientific, and St. Jude Medical. Dr. Naccarelli receives research support from Janssen and serves as a scientific advisor to Janssen, Glaxo-Smith-Kline, and Daiichi Sankyo. All other authors report no competing interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.